Dexcom (DXCM) Cash from Operations Growth (5y) (2015 - 2026)
Dexcom (DXCM) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.31% |
| Mar 31, 2026 | 80.02% |
| Dec 31, 2025 | 11.32% |
| Sep 30, 2025 | 34.92% |
| Jun 30, 2025 | 14.48% |
| Mar 31, 2025 | 149.53% |
| Dec 31, 2024 | 15.97% |
| Sep 30, 2024 | 16.12% |
| Jun 30, 2024 | 34.07% |
| Mar 31, 2024 | 77.72% |
| Dec 31, 2023 | 31.72% |
| Sep 30, 2023 | 36.50% |
| Jun 30, 2023 | 35.67% |
| Mar 31, 2023 | 81.80% |
| Dec 31, 2022 | 26.32% |
| Sep 30, 2022 | 51.95% |
| Jun 30, 2022 | 64.60% |
| Mar 31, 2022 | 198.42% |
| Dec 31, 2021 | 51.40% |
| Sep 30, 2021 | 60.80% |